Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,202 | $3,364 | $2,169 | $2,290 |
| - Cash | $128 | $136 | $437 | $336 |
| + Debt | $7 | $0 | $1 | $1 |
| Enterprise Value | $5,081 | $3,228 | $1,733 | $1,955 |
| Revenue | $675 | $482 | $402 | $366 |
| % Growth | 39.9% | 20% | 9.8% | – |
| Gross Profit | $664 | $476 | $396 | $361 |
| % Margin | 98.4% | 98.7% | 98.7% | 98.6% |
| EBITDA | $138 | $108 | $114 | $128 |
| % Margin | 20.5% | 22.5% | 28.3% | 35% |
| Net Income | $140 | $106 | $101 | $113 |
| % Margin | 20.7% | 22% | 25.2% | 30.7% |
| EPS Diluted | 1.23 | 0.94 | 0.87 | 0.89 |
| % Growth | 30.9% | 8% | -2.2% | – |
| Operating Cash Flow | $198 | $127 | $120 | $168 |
| Capital Expenditures | -$2 | -$0 | -$0 | -$0 |
| Free Cash Flow | $196 | $127 | $120 | $167 |